Due to retinal ischemia during diabetes, the balance between pro- and anti-angiogenic molecules is disrupted, leading to up-regulation of pro-angiogenic VEGF and down-regulation of anti-angiogenic PEDF [27,28]. This evidence concerns the gene SERPINF1 and diabetes mellitus.